WHO promises to make insulin easier for diabetes patients during a pandemic

The Covid-19 pandemic has an impact on all sectors, especially health. Includes patients with a history of previous comorbidities who are difficult to get treatment. Moreover, diabetes patients are one of the vulnerable groups. They are increasingly afraid to seek treatment.

Not only that, access to diabetes drugs has also been delayed due to Covid-19. A recent World Health Organization (WHO) survey found that 50 percent of countries had experienced diabetes services interruption during the coronavirus pandemic.

Global health experts have gathered to discuss how access to insulin and medical devices can be improved for diabetics around the world. Representatives from the World Health Organization (WHO) get together with key international health partners to tackle issues impacting the diabetes community.

Diabetes is the seventh cause of death in the world. And also a condition that leads to other major health problems, such as amputation of the lower limbs, heart attacks, strokes, kidney failure and blindness.

Those with type 1 diabetes, insulin is an essential medicine. But in many countries people still struggle to buy it.

This medication is also needed among some people with type 2 diabetes, although in the early stages the condition can be managed with diet, exercise, and oral medication. According to WHO, about 60 million people worldwide with type 2 diabetes need insulin, but only 50 percent receive it.

“This is a failure in society and the global community as a whole that people who need insulin have to face financial difficulties to buy it and risk their lives,” said WHO Director General Dr Tedros Adhanom Ghebreyesus, as reported by Diabetes.co.uk, Friday (16/16 / 10).

To address this problem, WHO wants to enhance global partnerships to ensure adoption of a patient-centered approach and access to essential diabetes drugs. Including insulin and related devices, must be significantly increased.

–